Cadwalader allows sharing content.
Email to a friend or colleague:
From
To
Subject
Email Technology and medical companies around the world are rising to meet the challenges created by the COVID-19 pandemic, in many cases turning to artificial intelligence (AI) and super computers to develop life-saving treatments for the disease as quickly as possible. While the use of AI will undoubtedly bring tremendous innovation, the data, test results and any inventions resulting from its use will also raise questions about how to best protect these innovations and who should get credit as an inventor. https://www.cadwalader.com/resources/articles/use-of-ai-to-treat-covid-19-shows-novel-inventorship-issues